Biotech Spinners Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 23-12-2024
- Paid Up Capital ₹ 3.00 M
as on 23-12-2024
- Company Age 7 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.14 Cr
as on 23-12-2024
- Satisfied Charges ₹ 5.58 M
as on 23-12-2024
- Revenue -52.28%
(FY 2022)
- Profit -68.70%
(FY 2022)
- Ebitda -10.42%
(FY 2022)
- Net Worth -3.85%
(FY 2022)
- Total Assets -6.73%
(FY 2022)
About Biotech Spinners
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 3.00 M.
The company currently has active open charges totaling ₹2.14 Cr. The company has closed loans amounting to ₹5.58 M, as per Ministry of Corporate Affairs (MCA) records.
Bappi Debnath and Ammeen Mohamed serve as directors at the Company.
- CIN/LLPIN
U18100TZ2017PTC029353
- Company No.
029353
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Aug 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Company Details
- Location
Coimbatore, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Biotech Spinners?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ammeen Mohamed  | Managing Director | 18-Aug-2017 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bappi Debnath | Director | 18-Aug-2017 | Current |
Financial Performance of Biotech Spinners.
Biotech Spinners Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 52.28% decrease. The company also saw a substantial fall in profitability, with a 68.7% decrease in profit. The company's net worth dipped by a decrease of 3.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biotech Spinners?
In 2022, Biotech Spinners had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 07 Jan 2022 | ₹0.45 M | Open |
Indian Overseas Bank Creation Date: 20 Apr 2020 | ₹8.63 M | Open |
Indian Overseas Bank Creation Date: 27 Dec 2018 | ₹1.23 Cr | Open |
How Many Employees Work at Biotech Spinners?
Unlock and access historical data on people associated with Biotech Spinners, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biotech Spinners, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biotech Spinners's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
